Showing 1 posts of 1 posts found.
NICE has revealed that it has passed draft guidance that recommends Novartis’ Extavia (interferon beta 1b) for the treatment of …
Dermatology leader Doncker is new Onicor CEO
East London pharmacies pilot cholesterol-lowering injections to cut waiting times
Weber is new CMO at Sensorion
Charity commits £800,000 to AI research into late breast cancer recurrence
AstraZeneca’s Trixeo approved in EU for asthma in patients aged 12 and over